---
title: "OS Therapies Incorporated (OSTX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/OSTX.US.md"
symbol: "OSTX.US"
name: "OS Therapies Incorporated"
industry: "生物技术"
---

# OS Therapies Incorporated (OSTX.US)

| Item | Detail |
|------|--------|
| Industry | 生物技术 |
| Location | 美股市场 |
| Website | [ostherapies.com](https://ostherapies.com) |

## Company Profile

OS Therapies Incorporated 是一家临床阶段的生物制药公司，专注于在美国识别、开发和商业化骨肉瘤及其他实体肿瘤的治疗方案。其产品管线包括 OST-HER2，一种针对骨肉瘤患者的现成免疫疗法；以及 OST-tunable 药物偶联物（OST-tADC），这是一种抗体药物偶联物（ADC）硅氧烷链接技术，具有可调 pH 敏感的硅链接器的即插即用平台。OS Therapies Incorporated 成立于 2018 年，总部位于马里兰州格雷森维尔

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -2.05 | 261/604 | - | - | - |
| PB | 11.42 | 382/604 | 15.21 | 14.13 | 12.59 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-05T05:00:00.000Z

Total Analysts: **5**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 3 | 60% |
| Overweight | 1 | 20% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.18 |
| Highest Target | 20.00 |
| Lowest Target | 6.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/OSTX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/OSTX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/OSTX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.